Christopher Hite
EVP & Chairman, Partnering at Royalty Pharma · 12 reported transactions in 1 company · latest trade Sep 22, 2026
Their trades
Sold | Sep 22, 2026 | Sep 22, 2026 close $58.52 → Oct 29, 2026 close $65.93. S&P 500 −0.5% over the same days. | ||
Sold | Sep 22, 2026 | Sep 22, 2026 close $58.52 → Oct 29, 2026 close $65.93. S&P 500 −0.5% over the same days. | ||
Sold | Jun 30, 2026 | Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days. | ||
Sold | Jun 30, 2026 | Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days. | ||
Sold | Jun 30, 2026 | Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days. | ||
Sold | Jun 30, 2026 | Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days. | ||
Sold | Jun 23, 2026 | Jun 23, 2026 close $55.35 → Oct 29, 2026 close $65.93. S&P 500 +4.9% over the same days. | ||
Sold | Jun 23, 2026 | Jun 23, 2026 close $55.35 → Oct 29, 2026 close $65.93. S&P 500 +4.9% over the same days. |
SoldRoyalty Pharma
$231.4K
Sep 22, 2026 close $58.52 → Oct 29, 2026 close $65.93. S&P 500 −0.5% over the same days.
SoldRoyalty Pharma
$5.62M
Sep 22, 2026 close $58.52 → Oct 29, 2026 close $65.93. S&P 500 −0.5% over the same days.
SoldRoyalty Pharma
$34.3K
Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days.
SoldRoyalty Pharma
$1.66M
Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days.
SoldRoyalty Pharma
$145.8K
Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days.
SoldRoyalty Pharma
$5.51M
Jun 30, 2026 close $56.07 → Oct 29, 2026 close $65.93. S&P 500 +3.0% over the same days.
SoldRoyalty Pharma
$6.41M
Jun 23, 2026 close $55.35 → Oct 29, 2026 close $65.93. S&P 500 +4.9% over the same days.
SoldRoyalty Pharma
$1.75M
Jun 23, 2026 close $55.35 → Oct 29, 2026 close $65.93. S&P 500 +4.9% over the same days.